Found: 32
Select item for more details and to access through your institution.
89% Vichy mineralizing water with hyaluronic acid is a well‐tolerated adjunct treatment that helps restore skin barrier function in dry skin‐related inflammatory dermatoses and post‐procedure skin care: A Canadian study.
- Published in:
- Journal of Cosmetic Dermatology, 2021, v. 20, n. 7, p. 2148, doi. 10.1111/jocd.14116
- By:
- Publication type:
- Article
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 6, p. 596, doi. 10.1001/jamadermatol.2023.0627
- By:
- Publication type:
- Article
Follow-up of Patients With Keratinocyte Carcinoma: A Systematic Review of Clinical Practice Guidelines.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Érythème polymorphe majeur associé à une infection au SRAS-CoV-2 chez un patient à la peau foncée.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2024, v. 196, n. 2, p. E61, doi. 10.1503/cmaj.230926-f
- By:
- Publication type:
- Article
Erythema multiforme major associated with SARS-CoV-2 infection in a patient with skin of colour.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2023, v. 195, n. 46, p. E1581, doi. 10.1503/cmaj.230926
- By:
- Publication type:
- Article
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2653, doi. 10.1007/s13555-024-01243-8
- By:
- Publication type:
- Article
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2457, doi. 10.1007/s13555-024-01240-x
- By:
- Publication type:
- Article
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1145, doi. 10.1007/s13555-024-01158-4
- By:
- Publication type:
- Article
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 441, doi. 10.1007/s13555-023-01075-y
- By:
- Publication type:
- Article
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2247, doi. 10.1007/s13555-023-01000-3
- By:
- Publication type:
- Article
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 867, doi. 10.1007/s13555-023-00905-3
- By:
- Publication type:
- Article
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 5, p. 1073, doi. 10.1007/s13555-022-00722-0
- By:
- Publication type:
- Article
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 5, p. 1181, doi. 10.1007/s13555-022-00721-1
- By:
- Publication type:
- Article
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 253, doi. 10.1007/s13555-021-00642-5
- By:
- Publication type:
- Article
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2123, doi. 10.1007/s13555-021-00621-w
- By:
- Publication type:
- Article
Practical Management of Patients with Atopic Dermatitis on Dupilumab.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1805, doi. 10.1007/s13555-021-00586-w
- By:
- Publication type:
- Article
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 4, p. 1357, doi. 10.1007/s13555-021-00558-0
- By:
- Publication type:
- Article
Psoriasis Prevalence and Severity by Expert Elicitation.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 3, p. 1053, doi. 10.1007/s13555-021-00518-8
- By:
- Publication type:
- Article
734 - Efficacy and safety of upadacitinib vs dupliumab in adults and adolescents with moderate-to-severe atopic dermatitis: results of an open-label, efficacy assessor-blinded head-to-head phase 3b/4 study (Level Up).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.107
- By:
- Publication type:
- Article
718 - Dupilumab reduces the number of lesions in adult patients with prurigo nodularis presenting with multiple lesion morphologies: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.091
- By:
- Publication type:
- Article
650 - Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.029
- By:
- Publication type:
- Article
638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.019
- By:
- Publication type:
- Article
619 - Lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients not adequately controlled or non-eligible for cyclosporine: a placebo-controlled, randomized phase 3 clinical study (ADvantage).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.005
- By:
- Publication type:
- Article
Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii8, doi. 10.1093/bjd/ljad498.010
- By:
- Publication type:
- Article
402 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.025
- By:
- Publication type:
- Article
393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.018
- By:
- Publication type:
- Article
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 6, p. 810, doi. 10.1093/bjd/ljad060
- By:
- Publication type:
- Article
The Treat-to-Target Project in Atopic Dermatitis: One Year On.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.5382
- By:
- Publication type:
- Article
Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15777
- By:
- Publication type:
- Article